Follow The Filings

NTNX Nutanix

Nutanix earnings company data as of 4:49 AM ET 10/23

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 24 Nov EPS 0.29 — —
Rev — — —
FY2026 Q3 26 Aug EPS 0.49 — —
Rev — — —

Insider trades

Open-market buys and sales by NTNX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NTNX insider trades
  • None no insider bought on the open market
  • $7.4M sold by 1 insider outside a trading plan
  • $49.7M sold by 3 insiders under 10b5-1 plans
  1. Rukmini Sivaraman CFO
    Planned sale
    $17.3M 232,712 shares at $74.55 72% of stake
    Traded Oct 12 Filed Oct 13
  2. Teresa Gayle Sheppard Director
    Planned sale
    $258K 3,500 shares at $73.67 13% of stake
    Traded Oct 9 Filed Oct 9
  3. Rajiv Ramaswami CEO
    Planned sale
    $29.5M 400,000 shares at $73.65 49% of stake
    Traded Oct 6–7 Filed Oct 8
  4. Tarkan Maner President and CCO
    Sale
    $4.8M 69,778 shares at $68.23 68% of stake
    Traded Sep 24 Filed Sep 25
  5. Rukmini Sivaraman CFO
    Planned sale
    $2.7M 38,139 shares at $70.00 11% of stake
    Traded Sep 17 Filed Sep 17
  6. Tarkan Maner President and CCO
    Sale
    $2.7M 49,259 shares at $54.14 47% of stake
    Traded May 29–Jun 1 Filed Jun 2

Also filed in the last 12 months, not counted as buying or selling: 55 option exercises, 19 stock grants, and 15 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
DEF 14A
DEFA14A
8-K 5.02
8-K 5.02
10-K
8-K 2.02,9.01
8-K 2.05
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 3.02
SCHEDULE 13G —
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 5.03,9.01
10-Q
8-K 2.02,3.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.